APA

Ott H. M., Graves A. P., Pappalardi M. B., Huddleston M., Halsey W. S., Hughes A. M., Groy A., Dul E., Jiang Y., Bai Y., Annan R., Verma S. K., Knight S. D., Kruger R. G., Dhanak D., Schwartz B., Tummino P. J., Creasy C. L. & McCabe M. T. (20150811). A687V EZH2 is a driver of histone H3 lysine 27 (H3K27) hypertrimethylation. : Molecular cancer therapeutics.

Chicago

Ott Heidi M, Graves Alan P, Pappalardi Melissa B, Huddleston Michael, Halsey Wendy S, Hughes Ashley M, Groy Arthur, Dul Edward, Jiang Yong, Bai Yuchen, Annan Roland, Verma Sharad K, Knight Steven D, Kruger Ryan G, Dhanak Dashyant, Schwartz Benjamin, Tummino Peter J, Creasy Caretha L and McCabe Michael T. 20150811. A687V EZH2 is a driver of histone H3 lysine 27 (H3K27) hypertrimethylation. : Molecular cancer therapeutics.

Harvard

Ott H. M., Graves A. P., Pappalardi M. B., Huddleston M., Halsey W. S., Hughes A. M., Groy A., Dul E., Jiang Y., Bai Y., Annan R., Verma S. K., Knight S. D., Kruger R. G., Dhanak D., Schwartz B., Tummino P. J., Creasy C. L. and McCabe M. T. (20150811). A687V EZH2 is a driver of histone H3 lysine 27 (H3K27) hypertrimethylation. : Molecular cancer therapeutics.

MLA

Ott Heidi M, Graves Alan P, Pappalardi Melissa B, Huddleston Michael, Halsey Wendy S, Hughes Ashley M, Groy Arthur, Dul Edward, Jiang Yong, Bai Yuchen, Annan Roland, Verma Sharad K, Knight Steven D, Kruger Ryan G, Dhanak Dashyant, Schwartz Benjamin, Tummino Peter J, Creasy Caretha L and McCabe Michael T. A687V EZH2 is a driver of histone H3 lysine 27 (H3K27) hypertrimethylation. : Molecular cancer therapeutics. 20150811.